Multimodal management of tenosynovial giant cell tumors (TGCT) in the landscape of new druggable targets
{{output}}
Tenosynovial giant cell tumor (TGCT) is a rare, benign, locally aggressive synovial based neoplastic process that can result in functional debilitation and end-stage arthrtitis. Although surgical resection is the primary treatment modality, novel systemic ther... ...